Elevance Health Inc. (0HG8.L)
USD 425.57
(3.51%)
USD 425.57
(3.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 5.98 Billion USD | 1.58% |
| 2022 | 5.89 Billion USD | -4.29% |
| 2021 | 6.1 Billion USD | 34.69% |
| 2020 | 4.57 Billion USD | -4.89% |
| 2019 | 4.8 Billion USD | 28.19% |
| 2018 | 3.75 Billion USD | -2.41% |
| 2017 | 3.84 Billion USD | 55.59% |
| 2016 | 2.46 Billion USD | -3.52% |
| 2015 | 2.56 Billion USD | -0.38% |
| 2014 | 2.56 Billion USD | 3.21% |
| 2013 | 2.65 Billion USD | -6.24% |
| 2012 | 2.65 Billion USD | 0.33% |
| 2011 | 2.64 Billion USD | -8.33% |
| 2010 | 2.88 Billion USD | -39.17% |
| 2009 | 4.74 Billion USD | 90.54% |
| 2008 | 2.49 Billion USD | -25.55% |
| 2007 | 3.34 Billion USD | 8.09% |
| 2006 | 3.09 Billion USD | 25.61% |
| 2005 | 2.46 Billion USD | 156.62% |
| 2004 | 960.1 Million USD | 24.0% |
| 2003 | 774.3 Million USD | 41.01% |
| 2002 | 549.1 Million USD | 60.46% |
| 2001 | 342.2 Million USD | 51.42% |
| 2000 | 226 Million USD | 403.34% |
| 1999 | 44.9 Million USD | -73.96% |
| 1998 | 172.4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 1.01 Billion USD | -55.83% |
| 2024 Q2 | 2.3 Billion USD | 2.4% |
| 2024 Q1 | 2.24 Billion USD | 162.38% |
| 2023 Q1 | 1.98 Billion USD | 109.59% |
| 2023 Q2 | 1.85 Billion USD | -6.84% |
| 2023 FY | 5.98 Billion USD | 1.58% |
| 2023 Q3 | 1.28 Billion USD | -30.44% |
| 2023 Q4 | 856 Million USD | -33.59% |
| 2022 Q2 | 1.63 Billion USD | -8.5% |
| 2022 Q1 | 1.78 Billion USD | 57.34% |
| 2022 Q3 | 1.6 Billion USD | -2.08% |
| 2022 Q4 | 949 Million USD | -40.8% |
| 2022 FY | 5.89 Billion USD | -4.29% |
| 2021 Q1 | 1.66 Billion USD | 202.18% |
| 2021 Q2 | 1.79 Billion USD | 7.69% |
| 2021 Q4 | 1.13 Billion USD | -24.65% |
| 2021 Q3 | 1.5 Billion USD | -15.84% |
| 2021 FY | 6.15 Billion USD | 34.69% |
| 2020 Q4 | 551 Million USD | 148.2% |
| 2020 Q3 | 222 Million USD | -90.25% |
| 2020 FY | 4.57 Billion USD | -4.89% |
| 2020 Q1 | 1.52 Billion USD | 63.06% |
| 2020 Q2 | 2.27 Billion USD | 49.44% |
| 2019 Q3 | 1.18 Billion USD | 3.86% |
| 2019 Q1 | 1.55 Billion USD | 264.94% |
| 2019 Q2 | 1.13 Billion USD | -26.56% |
| 2019 Q4 | 934 Million USD | -21.05% |
| 2019 FY | 4.8 Billion USD | 28.19% |
| 2018 Q4 | 425 Million USD | -55.73% |
| 2018 FY | 3.75 Billion USD | -2.41% |
| 2018 Q3 | 960 Million USD | -8.92% |
| 2018 Q2 | 1.05 Billion USD | -19.66% |
| 2018 Q1 | 1.31 Billion USD | 6.61% |
| 2017 Q2 | 855.3 Million USD | -15.31% |
| 2017 Q3 | 747 Million USD | -12.66% |
| 2017 Q4 | 1.23 Billion USD | 64.75% |
| 2017 FY | 3.84 Billion USD | 55.59% |
| 2017 Q1 | 1 Billion USD | 174.13% |
| 2016 Q3 | 617.8 Million USD | -20.86% |
| 2016 Q1 | 703 Million USD | 288.61% |
| 2016 FY | 2.46 Billion USD | -3.52% |
| 2016 Q4 | 368.4 Million USD | -40.37% |
| 2016 Q2 | 780.6 Million USD | 11.04% |
| 2015 Q4 | 180.9 Million USD | -72.37% |
| 2015 Q3 | 654.8 Million USD | -23.78% |
| 2015 Q2 | 859.1 Million USD | -0.71% |
| 2015 FY | 2.56 Billion USD | -0.38% |
| 2015 Q1 | 865.2 Million USD | 70.75% |
| 2014 FY | 2.56 Billion USD | 3.21% |
| 2014 Q4 | 506.7 Million USD | -19.69% |
| 2014 Q3 | 630.9 Million USD | -13.71% |
| 2014 Q2 | 731.1 Million USD | 4.29% |
| 2014 Q1 | 701 Million USD | 373.01% |
| 2013 Q2 | 800.1 Million USD | -9.61% |
| 2013 FY | 2.48 Billion USD | -6.24% |
| 2013 Q4 | 148.2 Million USD | -77.42% |
| 2013 Q3 | 656.2 Million USD | -17.99% |
| 2013 Q1 | 885.2 Million USD | 90.69% |
| 2012 Q2 | 643.6 Million USD | -24.86% |
| 2012 Q3 | 691.2 Million USD | 7.4% |
| 2012 Q4 | 464.2 Million USD | -32.84% |
| 2012 FY | 2.65 Billion USD | 0.33% |
| 2012 Q1 | 856.5 Million USD | 155.44% |
| 2011 Q4 | 335.3 Million USD | -50.92% |
| 2011 Q3 | 683.2 Million USD | -2.62% |
| 2011 Q2 | 701.6 Million USD | -24.28% |
| 2011 Q1 | 926.6 Million USD | 68.84% |
| 2011 FY | 2.64 Billion USD | -8.33% |
| 2010 Q2 | 722.4 Million USD | -17.61% |
| 2010 Q3 | 739.1 Million USD | 2.31% |
| 2010 Q4 | 548.8 Million USD | -25.75% |
| 2010 FY | 2.88 Billion USD | -39.17% |
| 2010 Q1 | 876.8 Million USD | -68.02% |
| 2009 Q4 | 2.74 Billion USD | 275.49% |
| 2009 Q2 | 693.5 Million USD | 19.49% |
| 2009 Q1 | 580.4 Million USD | 75.14% |
| 2009 FY | 4.74 Billion USD | 90.54% |
| 2009 Q3 | 730.2 Million USD | 5.29% |
| 2008 Q4 | 331.4 Million USD | -59.62% |
| 2008 Q2 | 750.5 Million USD | 27.61% |
| 2008 Q3 | 820.7 Million USD | 9.35% |
| 2008 Q1 | 588.1 Million USD | -31.54% |
| 2008 FY | 2.49 Billion USD | -25.55% |
| 2007 Q4 | 859.1 Million USD | -1.03% |
| 2007 Q3 | 868 Million USD | 3.93% |
| 2007 Q2 | 835.2 Million USD | 6.65% |
| 2007 Q1 | 783.1 Million USD | -2.25% |
| 2007 FY | 3.34 Billion USD | 8.09% |
| 2006 Q4 | 801.1 Million USD | -1.2% |
| 2006 Q3 | 810.8 Million USD | 7.93% |
| 2006 Q2 | 751.2 Million USD | 2.65% |
| 2006 Q1 | 731.8 Million USD | 12.24% |
| 2006 FY | 3.09 Billion USD | 25.61% |
| 2005 Q2 | 559.4 Million USD | -8.55% |
| 2005 Q3 | 640.7 Million USD | 14.53% |
| 2005 FY | 2.46 Billion USD | 156.62% |
| 2005 Q4 | 652 Million USD | 1.76% |
| 2005 Q1 | 611.7 Million USD | 231.54% |
| 2004 Q2 | 237.9 Million USD | -19.52% |
| 2004 Q1 | 295.6 Million USD | 41.57% |
| 2004 FY | 960.1 Million USD | 24.0% |
| 2004 Q4 | 184.5 Million USD | -23.79% |
| 2004 Q3 | 242.1 Million USD | 1.77% |
| 2003 Q3 | 196.5 Million USD | 10.83% |
| 2003 Q2 | 177.3 Million USD | -7.51% |
| 2003 FY | 774.3 Million USD | 41.01% |
| 2003 Q4 | 208.8 Million USD | 6.26% |
| 2003 Q1 | 191.7 Million USD | 11.52% |
| 2002 Q3 | 171.2 Million USD | 61.21% |
| 2002 FY | 549.1 Million USD | 60.46% |
| 2002 Q2 | 106.2 Million USD | 6.41% |
| 2002 Q1 | 99.8 Million USD | 13.8% |
| 2002 Q4 | 171.9 Million USD | 0.41% |
| 2001 FY | 342.2 Million USD | 51.42% |
| 2001 Q3 | 111.5 Million USD | 0.0% |
| 2001 Q4 | 87.7 Million USD | -21.35% |
| 2000 FY | 226 Million USD | 403.34% |
| 1999 FY | 44.9 Million USD | -73.96% |
| 1998 FY | 172.4 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 4473.744% |
| Accuray Incorporated | -15.54 Million USD | 38613.992% |
| Align Technology, Inc. | 445.05 Million USD | -1245.233% |
| AxoGen, Inc. | -21.71 Million USD | 27669.534% |
| Boston Scientific Corporation | 1.59 Billion USD | -275.832% |
| CVS Health Corporation | 8.34 Billion USD | 28.248% |
| Cardinal Health, Inc. | 852 Million USD | -602.7% |
| Centene Corporation | 2.7 Billion USD | -121.577% |
| DaVita Inc. | 691.53 Million USD | -765.755% |
| HCA Healthcare, Inc. | 5.24 Billion USD | -14.212% |
| Hologic, Inc. | 789.5 Million USD | -658.328% |
| Humana Inc. | 2.48 Billion USD | -140.538% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -608.485% |
| Laboratory Corporation of America Holdings | 418 Million USD | -1332.297% |
| Masimo Corporation | 81.5 Million USD | -7246.012% |
| McKesson Corporation | 3 Billion USD | -99.434% |
| Patterson Companies, Inc. | 185.93 Million USD | -3120.012% |
| Quest Diagnostics Incorporated | 854 Million USD | -601.054% |
| ResMed Inc. | 1.02 Billion USD | -486.414% |
| Henry Schein, Inc. | 416 Million USD | -1339.183% |
| Teladoc Health, Inc. | -220.36 Million USD | 2816.819% |
| Universal Health Services, Inc. | 717.79 Million USD | -734.082% |
| Veeva Systems Inc. | 525.7 Million USD | -1038.852% |
| Baxter International Inc. | 2.65 Billion USD | -125.414% |
| Becton, Dickinson and Company | 1.48 Billion USD | -303.437% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | -232.981% |
| Danaher Corporation | 4.2 Billion USD | -42.548% |
| Stryker Corporation | 3.16 Billion USD | -89.163% |
| Medtronic plc | 3.67 Billion USD | -62.867% |